Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)

Authors not listed

Brigham and Women's Hospital · 2010

Abstract

The VITamin D and OmegA-3 Trial (VITAL; NCT 01169259) is a randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or omega-3 fatty acids, compared to placebo, reduce the incidence and/or progression of age-related macular degeneration (AMD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2010). Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL). <em>Brigham and Women's Hospital</em>. https://clinicaltrials.gov/study/NCT01782352
Vancouver
Anonymous. Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL). Brigham and Women's Hospital. 2010.
BibTeX
@misc{anon2010Agerel, title = {Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)}, author = {Anonymous}, journal = {Brigham and Women's Hospital}, year = {2010}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings